Research Summary
A digital biomarker refers to quantifiable and measurable physiological, behavioral, or biological data collected through digital devices and technologies, such as smartphones, wearables, or sensors. These data points are used to monitor and track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters like heart rate variability, activity levels, sleep patterns, cognitive performance, and even voice or speech characteristics. The integration of digital biomarkers into healthcare and medical research holds promise for early disease detection, personalized treatments, remote patient monitoring, and advancing our understanding of various health conditions.
According to DIResearch's in-depth investigation and research, the global Digital Biomarker market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Digital Biomarker include Philips, Johnson & Johnson, Pfizer, GE Healthcare, Novartis, Sanofi, GlaxoSmithKline, Bayer, Merck, Apple, Abbott Laboratories, Asahi Kasei, Biogen, Koneksa Health, Roche, Huma Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Digital Biomarker. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Digital Biomarker market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Digital Biomarker market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Digital Biomarker industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Digital Biomarker Include:
Philips
Johnson & Johnson
Pfizer
GE Healthcare
Novartis
Sanofi
GlaxoSmithKline
Bayer
Merck
Apple
Abbott Laboratories
Asahi Kasei
Biogen
Koneksa Health
Roche
Huma Therapeutics
Digital Biomarker Product Segment Include:
Passive Digital Biomarker
Active Digital Biomarker
Digital Biomarker Product Application Include:
Clinical Disease
Daily Health
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Digital Biomarker Industry PESTEL Analysis
Chapter 3: Global Digital Biomarker Industry Porter’s Five Forces Analysis
Chapter 4: Global Digital Biomarker Major Regional Market Size and Forecast Analysis
Chapter 5: Global Digital Biomarker Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Digital Biomarker Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Digital Biomarker Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Digital Biomarker Market Overview
- 1.1 Product Definition and Statistica Sclope
- 1.2 Digital Biomarker Product by Type
- 1.2.1 Passive Digital Biomarker
- 1.2.2 Active Digital Biomarker
- 1.3 Digital Biomarker Product by Application
- 1.3.1 Clinical Disease
- 1.3.2 Daily Health
- 1.4 Global Digital Biomarker Market Size Analysis (2020-2032)
- 1.5 Digital Biomarker Market Development Status and Trends
- 1.5.1 Digital Biomarker Industry Development Status Analysis
- 1.5.2 Digital Biomarker Industry Development Trends Analysis
- 2 Digital Biomarker Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Digital Biomarker Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Digital Biomarker Market Analysis by Regions
- 4.1 Global Digital Biomarker Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Digital Biomarker Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Digital Biomarker Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Digital Biomarker Revenue and Market Share Forecast by Region (2026-2032)
- 5 Global Digital Biomarker Market Size by Type and Application
- 5.1 Global Digital Biomarker Market Size by Type (2020-2032)
- 5.2 Global Digital Biomarker Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Digital Biomarker Market Size by Type
- 6.4 North America Digital Biomarker Market Size by Application
- 6.5 North America Digital Biomarker Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Digital Biomarker Market Size by Type
- 7.4 Europe Digital Biomarker Market Size by Application
- 7.5 Europe Digital Biomarker Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Digital Biomarker Market Size by Type
- 8.4 China Digital Biomarker Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Digital Biomarker Market Size by Type
- 9.4 APAC (excl. China) Digital Biomarker Market Size by Application
- 9.5 APAC (excl. China) Digital Biomarker Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Digital Biomarker Market Size by Type
- 10.4 Latin America Digital Biomarker Market Size by Application
- 10.5 Latin America Digital Biomarker Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Digital Biomarker Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Digital Biomarker Market Size by Type
- 11.4 Middle East & Africa Digital Biomarker Market Size by Application
- 11.5 Middle East & Africa Digital Biomarker Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Digital Biomarker Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Digital Biomarker Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Digital Biomarker Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Philips
- 13.1.1 Philips Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Philips Digital Biomarker Product Portfolio
- 13.1.3 Philips Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Johnson & Johnson
- 13.2.1 Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Johnson & Johnson Digital Biomarker Product Portfolio
- 13.2.3 Johnson & Johnson Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Pfizer
- 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Pfizer Digital Biomarker Product Portfolio
- 13.3.3 Pfizer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 GE Healthcare
- 13.4.1 GE Healthcare Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 GE Healthcare Digital Biomarker Product Portfolio
- 13.4.3 GE Healthcare Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Novartis
- 13.5.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Novartis Digital Biomarker Product Portfolio
- 13.5.3 Novartis Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Sanofi
- 13.6.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Sanofi Digital Biomarker Product Portfolio
- 13.6.3 Sanofi Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 GlaxoSmithKline
- 13.7.1 GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 GlaxoSmithKline Digital Biomarker Product Portfolio
- 13.7.3 GlaxoSmithKline Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 Bayer
- 13.8.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 Bayer Digital Biomarker Product Portfolio
- 13.8.3 Bayer Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Merck
- 13.9.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Merck Digital Biomarker Product Portfolio
- 13.9.3 Merck Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Apple
- 13.10.1 Apple Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Apple Digital Biomarker Product Portfolio
- 13.10.3 Apple Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.11 Abbott Laboratories
- 13.11.1 Abbott Laboratories Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.11.2 Abbott Laboratories Digital Biomarker Product Portfolio
- 13.11.3 Abbott Laboratories Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.12 Asahi Kasei
- 13.12.1 Asahi Kasei Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.12.2 Asahi Kasei Digital Biomarker Product Portfolio
- 13.12.3 Asahi Kasei Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.13 Biogen
- 13.13.1 Biogen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.13.2 Biogen Digital Biomarker Product Portfolio
- 13.13.3 Biogen Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.14 Koneksa Health
- 13.14.1 Koneksa Health Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.14.2 Koneksa Health Digital Biomarker Product Portfolio
- 13.14.3 Koneksa Health Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.15 Roche
- 13.15.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.15.2 Roche Digital Biomarker Product Portfolio
- 13.15.3 Roche Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.16 Huma Therapeutics
- 13.16.1 Huma Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.16.2 Huma Therapeutics Digital Biomarker Product Portfolio
- 13.16.3 Huma Therapeutics Digital Biomarker Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Digital Biomarker Industry Chain Analysis
- 14.2 Digital Biomarker Industry Raw Material and Suppliers Analysis
- 14.2.1 Digital Biomarker Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Digital Biomarker Typical Downstream Customers
- 14.4 Digital Biomarker Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook